Made available in DSpace on 2015-04-14T13:30:28Z (GMT). No. of bitstreams: 1 451795.pdf: 9844032 bytes, checksum: abd171b9947156a56d52eef795138daf (MD5) Previous issue date: 2013-09-13 / In this study we investigated the immunodetection of VEGF, ANG-1 and ANG-2, as well as the number of blood vessels in specimens of reticular (ROLP) and atrophic-erosive oral lichen planus (AEOLP). In addition, were included the control groups oral epithelial hyperplasia (OFH), oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC) in order to find a relation between those angiogenics growth factors and biological behavior. Biopsy specimens diagnosed at the Oral Medicine Division of PUCRS, Brazil, were selected and distributed into the following groups ROLP (n=21); AEOLP (n=11); OFH (n=10); OED (n=10); and OSCC (n=10). They were subjected to immunohistochemical processing with primary antibodies anti-VEGF, anti-ANG-1 and anti-ANG-2. The results do not revelead significant difference in the immunodetection of ANG-1 and ANG-2 between the OLP groups. The ROLP group showed significantly higher immunodetection of VEGF (P=0.01) compared with the AEOLP group. There was no significant difference in the number of blood vessels between the OLP groups (P=0.393). In comparative analysis of OLP with control groups, ROLP and AEOLP cases were considered together, forming the OLP group (n=32). The comparison of immunodetection of those growth factors between the OLP group and each control group showed significantly higher values of ANG-1 in the OLP group compared to the OFH group (P=0.043) and no significant difference in ANG-2. VEGF immunodetection in the OLP group was significantly higher than in the OFH group (P=0.003) and significantly lower compared to the OSCC group (P=0.032). No correlation was observed between growth factors evaluated in the different groups studied. The results of immunodetection of VEGF, ANG-1 and ANG-2 and the lack of significant difference in the number of blood vessels between ROLP and AEOLP groups indicate that angiogenesis in OLP can not be associated to the different clinical forms of this disease. The lack of correlation between the growth factors in the different lesions indicates the involvement of other pro-angiogenic agents in vascular neoformation and reflects the complexity of this process. Furthermore, immunodetection of growth factors evaluated was similar between OLP and OED, suggesting that angiogenesis in OLP may behave similarly to the epithelial dysplastic lesions. / Neste estudo foi investigada a imunodetec??o do VEGF e das angiopoietinas (ANG) 1 e 2, bem como o n?mero de vasos sangu?neos em esp?cimes de l?quen plano oral reticular (LPOR) e atr?fico-erosivo (LPOAE). Al?m disso, foram inclu?dos os grupos-controle hiperplasia fibroepitelial (HFO), displasia epitelial (DEO) e carcinoma espinocelular (CEO) orais, a fim de encontrar uma rela??o entre esses fatores de crescimento angiog?nicos e comportamento biol?gico. Foram obtidos esp?cimes de bi?psias do arquivo do Servi?o de Estomatologia e Preven??o do C?ncer Bucomaxilofacial do Hospital S?o Lucas da PUCRS, os quais foram distribu?dos nos grupos LPOR (n=21); LPOAE (n=11); HFO (n=10); DEO (n=10); CEO (n=10) e, posteriormente, submetidos ao processamento imunoistoqu?mico com os anticorpos prim?rios anti-VEGF, anti-ANG-1 e anti-ANG-2. Os resultados n?o revelaram diferen?a significativa na imunodetec??o da ANG-1 e ANG-2 entre os grupos l?quen plano oral (LPO). No entanto, o grupo LPOR apresentou imunodetec??o significativamente superior do VEGF (p=0,01) comparado ao grupo LPOAE. Com rela??o ao n?mero de vasos sangu?neos, a compara??o entre os grupos LPO n?o mostrou diferen?a significativa entre ambos (p=0,393). Na an?lise comparativa com os grupos-controle, os casos de LPOR e LPOAE foram considerados em conjunto, formando o grupo LPO (n=32). A compara??o da imunodetec??o dos fatores de crescimento entre o grupo LPO com cada grupocontrole revelou valores significativamente superiores da ANG-1 no grupo LPO em rela??o ao grupo HFO (p=0,043) e aus?ncia de diferen?a significativa nos valores da ANG-2. A imunodetec??o do VEGF foi significativamente superior no grupo LPO em rela??o ao grupo HFO (p=0,003) e inferior quando comparada ao grupo CEO (p=0,032). N?o foi observada correla??o entre os fatores de crescimento avaliados nos diferentes grupos estudados. Os resultados observados na imunodetec??o do VEGF, ANG-1 e ANG-2 e a falta de diferen?a significativa no n?mero de vasos entre os grupos LPOR e LPOAE indicam que a angiog?nese no LPO possa n?o estar associada ?s diferentes formas cl?nicas desta doen?a. A falta de correla??o entre estes fatores de crescimento nos diferentes tipos de les?es estudadas indica o envolvimento de outras citocinas pr?-angiog?nicas, al?m daquelas avaliadas neste estudo, na neoforma??o vascular e reflete a complexidade deste processo. Por outro lado, a imunodetec??o dos fatores de crescimento avaliados foi semelhante entre os grupos LPO e DEO, sugerindo que a angiog?nese no LPO possa comportar-se de modo semelhante ao de les?es displ?sicas epiteliais.

Made available in DSpace on 2015-04-14T13:34:30Z (GMT). No. of bitstreams: 1 401957.pdf: 1657305 bytes, checksum: 04257e1ae89d98b9a3d6b2d4e1a72a54 (MD5) Previous issue date: 2008-03-28 / A express?o do fator tecidual (FT) tem sido associada ? maior densidade microvascular e a um pior progn?stico nos tumores de pr?stata, mama, pulm?o, c?lon e reto. Nos c?nceres de bexiga, maior densidade microvascular tem se correlacionado com tumores de maior grau, est?gio e mau progn?stico, mas a express?o do FT foi pouco estudada. No presente estudo, analisamos a express?o imunoistoqu?mica do FT e a densidade microvascular em esp?cimes de 67 pacientes submetidos ? ressec??o transuretral de carcinomas uroteliais de bexiga, correlacionando-os a est?gio, grau e sobrevida geral. A densidade microvascular n?o se correlacionou com est?gio, grau ou sobrevida em nossa amostragem. Cinq?enta e um pacientes (76,01%) apresentaram tumores com >25% das c?lulas tumorais corando-se intensamente para FT. N?o houve associa??o entre express?o do FT, est?gio e grau. No entanto, identificou-se correla??o estatisticamente significativa entre a intensidade de express?o do FT e a densidade microvascular. Al?m disso, houve diferen?a estat?stica quanto ? sobrevida geral entre o grupo com baixa express?o ( 25% das c?lulas corando-se intensamente) e os grupos com alta express?o (>25% das c?lulas corando-se intensamente) de FT. Sumarizando, maior express?o do FT correlacionou-se ? maior angiog?nese tumoral e ? menor sobrevida geral em nossa casu?stica.

Made available in DSpace on 2015-04-14T13:35:59Z (GMT). No. of bitstreams: 1 460424.pdf: 208542 bytes, checksum: c614e57b83b06eea8ef4c11836bbd946 (MD5) Previous issue date: 2014-01-14 / Oral cancer is among the six most common types of cancer worldwide, considered as the seventh most frequent in the Brazil. Tumor angiogenesis has become a promising target for the treatment of malignancies. Methods that allow three-dimensional evaluation of the vascular network of tumors have a great importance to assess the effects of antiangiogenic treatments in tumors. The objective of this study was to evaluate the effect of sunitinib maleate and the metronomic chemotherapy with cyclophosphamide on the vascular network of the oral squamous cell carcinoma by scanning electron microscopy (SEM) of corrosion casts. 24 Syrian hamsters (Mesocricetus auratus) were divided into three groups of eight animals each and had their right buccal pouches submitted to tumor induction with dimethylbenzanthracene and carbamide peroxide for 55 days. Following, the animals were maintained without treatment (group I) or receiving sunitinib (group II), or cyclophosphamide (group III) for a period of 4 weeks. After the treatment, six animals of each group had their vascular networks casted by Mercox? resin and analyzed qualitatively and quantitatively by SEM. The two remaining animals of each group had their buccal pouches prepared for qualitative analysis by light microscopy. It was observed changes in the angioarchitecture of the pouches that were treated with these two drugs, suggesting an improvement in the tumors vascularization. The main changes caused by the treatments were the reduction of vessel tortuosity, the reestablishment of vascular hierarchy, besides the decrease of sprouting and intussusception images, compressed vessels, saccular dilations, and other vascular figures. Quantitative analysis of the samples exhibited a statistically significant reduction in vascular diameter and intervascular distances ofthe pouches treated with cyclophosphamide, when compared with the pouches no treated and those treated with sunitinb. The findings of the present study suggest that these two drugs may act in the vascular normalization of squamous cell carcinomas induced in hamster buccal pouch, however the metronomic chemotherapy exhibited superior results. / O c?ncer oral est? entre os seis tipos mais comuns de c?ncer no mundo, sendo o s?timo mais encontrado entre a popula??o brasileira. O processo de angiog?nese tumoral tem-se tornado um alvo promissor para o tratamento de neoplasias malignas. Os m?todos que permitem a avalia??o tridimensional da angioarquitetura dos tumores s?o de grande import?ncia na an?lise dos efeitos de tratamentos antiangiog?nico. Este trabalho visou avaliar o efeito do maleato de sunitinibe e da quimioterapia metron?mica com ciclofosfamida na vasculatura do carcinoma oral de c?lulas escamosas, atrav?s de microscopia eletr?nica de varredura (MEV) de r?plicas vasculares. Assim, 24 hamsters s?rios (Mesocricetus auratus) divididos em tr?s grupos de oito animais cada, tiveram suas bolsas jugais direitas submetidas ? indu??o tumoral com dimetilbenzantraceno e per?xido de carbamida por 55 dias, sendo mantidos por mais 4 semanas sem tratamento (grupo I), ou recebendo sunitinibe (grupo II), ou ciclofosfamida (grupo III). Ap?s o tratamento, seis animais de cada grupo tiveram suas redes vasculares moldadas pela resina Mercox? e analisadas qualitativa e quantitativamente em MEV. Os dois animais restantes de cada grupo tiveram suas bolsas qualitativamente analisadas em microscopia de luz. Foram observadas modifica??es na angioarquitetura das bolsas que receberam tratamento com os dois f?rmacos, o que gerou uma normaliza??o da vasculariza??o dos tumores. As principais modifica??es provocadas pelos tratamentos foram a redu??o da tortuosidade dos vasos, o reestabelecimento da hierarquia vascular, al?m da diminui??o de imagens de sprouting e intussuscep??es, vasos comprimidos, dilata??es saculares e outras figuras vasculares. A an?lise quantitativa das amostras evidenciou uma redu??o estatisticamente significativa do di?metro vascular e das dist?ncias intervasculares nas bolsas tratadas com ciclofosfamida, quando comparadas com as bolsas que n?o receberam tratamento e com aquelas tratadas com sunitinibe. Os achados do presente estudo sugerem que essas duas drogas podem atuar na normaliza??o da rede vascular no carcinoma de c?lulas escamosas induzido em bolsa jugal de hamster; no entanto a quimioterapia metron?mica apresentou resultados superiores.

Made available in DSpace on 2014-12-17T14:03:35Z (GMT). No. of bitstreams: 1 CelinaMPGD_TESE.pdf: 1816885 bytes, checksum: 1e39ca48cae61af571d696fef8f71be4 (MD5) Previous issue date: 2012-10-15 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / The present study examines the chemical composition and their effects on free radicals, inflammation, angiogenesis, coagulation, VEGF effects and cellular proliferation of a polysaccharides from alga Sargassum vulgare. The sulfated polysaccharide was extracted from brown seaweed by proteolysis with enzymes maxataze. The presence of proteins and sugars were observed in crude polysaccharides. Fractionation of this crude extract was made with growing concentration of acetone (0.3-1.5 v) and produced four groups of polysaccharides. Anionic polysaccharides from brown seaweed Sargassum vulgare, SV1and PSV1 were fractionated (SV1) and purified (PSV1), and displayed with high total sugars and sulfate content and very low level of protein. This fucan SV1 contains low levels of protein and high carbohydrate and sulfate content. This polysaccharides prolonged activated partial thromboplastin time (aPTT) at 50 μg (>240 s). SV1 was found to have no effect on prothrombin time (PT), corresponding to the extrinsic pathway of coagulation. SV1 exhibits high antithrombotic action in vivo, with a concentration ten times higher than heparin. Polysaccharides from S. vulgare promoted direct inhibition enzymatic activity of thrombin and stimulated enzymatic activity of FXa. SV1 showed optimal inhibitory activity of thrombin (50.2?0.28%) at a concentration of 25 μg/mL. Its antioxidant action on scavenging radicals by DPPH was (22%), indicating the polymer has no cytotoxic action (hemolytic) on ABO and Rh blood types in different erythrocyte groups and displays strong anti-inflammatory action on all concentrations tested in the carrageenan-induced paw edema model, demonstrated by reduced edema and cellular infiltration. Angiogenesis is a dynamic process of proliferation and differentiation. It requires endothelial proliferation, migration, and tube formation. In this context, endothelial cells are a preferred target for several studies and therapies. The antiangiogenic efficacy of polysaccharides was examined in vivo in the chick chorioallantoic membrane (CAM) model by using fertilized eggs. Decreases in the density of the capillaries were assessed and scored. The results showed that SV1 and PSV1 have an inhibitory effect on angiogenesis. These results were also confirmed by inhibition tubulogenesis in rabbit aorta endothelial cell (RAEC) in matrigel. These compounds were assessed in Apoptosis assay (Annexin V - FITC / PI) and cell viability by MTT assay of RAEC. These polysaccharides do not affect the viability and do not have apoptotic or necrotic action. RAEC cell when incubated with SV1 and PSV1showed inhibition of VEGF secretion, observed when compounds were incubated at 25, 50 and 100 μg/μL. The VEGF secretion with the RAEC cell line for 24 h, was more effective for PSV1 at 50 μg/μL(71.4%) than SV1 100 μg/μL (75.9%). SV1 and PSV1 had an antiproliferative action (47%) against tumor cell line HeLa. Our results indicate that these sulfated polysaccharides have antiangiogenic and antitumoral actions / O presente estudo analisa a composi??o qu?mica e seus efeitos sobre os radicais livres, inflama??o, angiog?nese, coagula??o, VEGF e prolifera??o celular dos polissacar?deos de uma alga Sargassum vulgare. O polissac?rido sulfatado foi extra?do a partir de algas marrons por prote?lise com a enzima maxataze. A presen?a de prote?nas e a??cares foram observados no cru de polissacarideos. Fracionamento do o extrato bruto foi feito com concentra??es crescente de acetona (0,3-1,5 v), produzindo quatro grupos de polissacarideos. Estes compostos ani?nicos da alga S. vulgare, foram fracionados (SV1) e purificados (PSV1) exibindo com alta a??cares totais e sulfatecontent e n?vel muito baixo de prote?nas.A fucana SV1 cont?m baixos n?veis de prote?na e de hidratos de carbono e alto teor de sulfato. Este polissacar?deos prolongou o tempo de tromboplastina parcial activada (aPTT) a 50 ug (>240 s). n?o foi observado qualquer efeito de SV1 sobre o tempo de protrombina (PT), que corresponde a via extr?nseca da coagula??o. SV1 exibiu alta a??o antitromb?tica in vivo, com uma concentra??o 10 vezes maior do que a heparina. SV1 promoveu a actividade de inibi??o enzim?tica direta da trombina e estimulou a atividade enzim?tica do FXa. Mostrou tamb?m, atividade inibidora optima de trombina (50,2 ? 0,28%) a uma concentra??o de 25 ug / mL. A sua ac??o anti-oxidante de radicais scavenging por DPPH foi de (22%), indicando que o pol?mero n?o tem qualquer a??o citot?xica (hemol?tica) em tipos de sangue ABO e Rh, em diferentes grupos de eritr?citos e exibindo alta a??o anti-inflamat?ria em edema de pata de ratos Wistar em todas as concentra??es testadas induzida por carragenina. Tal processo foi demonstrado por edema e infiltra??o celular. A angiogenese ? um processo din?mico de prolifera??o e diferencia??o. Ele requer prolifera??o endotelial, migra??o, e a forma??o do tubo. Neste contexto, as c?lulas endoteliais s?o um alvo preferido para muitos estudos e terapias. A efic?cia antiangiogenico de polissacar?deos foi examinada in vivo na membrana corioalant?ica pinto (CAM) usando-se ovos fertilizados. Diminui??es na densidade dos capilares foram avaliados e pontuados. Os resultados mostraram que SV1 e PSV1 tem um efeito inibidor da angiogenese. Estes resultados foram tamb?m confirmados por tubulogenesis inibi??o na c?lula endotelial da aorta de coelho (RAEC) em matrigel. C?lulas RAEC quando foram incubadas com SV1and PSV1 demonstraram inibi??o da secre??o de VEGF, a 25, 50 e 100 ug/mL. A secre??o de VEGF com a linha de c?lulas RAEC durante 24 h, foi mais eficaz para PSV1 a 50 ug / mL (71,4%) do que SV1 100 ug / mL (75,9%). SV1 e PSV1 posuiram uma ac??o antiproliferativa (47%) contra as c?lulas tumorais tipo HeLa. Estes compostos foram avaliados tamb?m, no ensaio de apoptose (anexina V - FITC / PI) e a viabilidade celular pelo ensaio de MTT de RAEC. Estes polissacar?deos n?o afetaram a viabilidade e n?o tiveram a??o apopt?tica ou necr?tica. Nossos resultados indicam que estes polissacar?deos sulfatados t?m a??es antiangiog?nica e antitumoral e constituem um importante alvo biol?gico e farmacol?gico

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-11T17:13:30Z No. of bitstreams: 1 HugoCostaNeto_DISSERT.pdf: 13162279 bytes, checksum: 29adac7972f3d85035eb3c3d51febbdb (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-14T21:07:41Z (GMT) No. of bitstreams: 1 HugoCostaNeto_DISSERT.pdf: 13162279 bytes, checksum: 29adac7972f3d85035eb3c3d51febbdb (MD5) / Made available in DSpace on 2016-07-14T21:07:41Z (GMT). No. of bitstreams: 1 HugoCostaNeto_DISSERT.pdf: 13162279 bytes, checksum: 29adac7972f3d85035eb3c3d51febbdb (MD5) Previous issue date: 2016-02-22 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico - CNPq / Dentre os cistos odontog?nicos comumente encontrados na pr?tica cl?nica odontol?gica, os cistos radiculares (CRs) e os cistos dent?geros (CDs) representam conjuntamente os mais frequentes cistos dos ossos gn?ticos. Os cistos odontog?nicos possuem origem inflamat?ria ou de desenvolvimento. No entanto, altera??es inflamat?rias secund?rias podem ser vistas nos ?ltimos. Alguns estudos t?m identificado os mast?citos nessas les?es c?sticas e sua poss?vel rela??o com a angiog?nese. Nesta perspectiva, a presente pesquisa objetivou avaliar e comparar a express?o imunoistoqu?mica do CD34 e da triptase em CDs inflamados e CRs e verificar se os mast?citos influenciam na angiog?nese destas les?es. Para tanto, foram selecionados 20 casos de CDs inflamados e 20 casos de CRs para serem submetidos ? an?lise morfol?gica e imunoistoqu?mica. A imunomarca??o de cada caso foi avaliada de forma quantitativa. Ap?s a identifica??o das ?reas de maior imunorreatividade, foram analisadas a densidade microvascular (DMV), a ?rea microvascular (AMV) e o per?metro microvascular (PMV) mensurados atrav?s da imunoexpress?o do CD34 e a densidade dos mast?citos (DMC) mensurada por meio da imunoexpress?o da triptase, realizadas nas mesmas ?reas dos consecutivos campos representativos de cada caso. A an?lise estat?stica foi realizada atrav?s dos testes de Mann-Whitney, Qui-quadrado de Pearson, Exato de Fisher e Correla??o de Spearman (r), com n?vel de signific?ncia estabelecido em 5% (p < 0,05). Os resultados demonstram diferen?as estatisticamente significativas entre as les?es c?sticas supracitadas em rela??o ? avalia??o da DMC (p < 0,001). Al?m disso, a an?lise da DMV revelou diferen?as estatisticamente significativas entre as les?es c?sticas (p = 0,007) e tamb?m no que se refere ? intensidade do infiltrado inflamat?rio (p = 0,021). Por fim, observou-se nos casos de CDs inflamados, moderada correla??o positiva entre a DMC e a AMV (r = 0,660; p = 0,002), assim como moderada correla??o positiva entre a DMC e o PMV (r = 0,634; p = 0,003). Face ao exposto, pode-se concluir que os mast?citos participam em diferentes etapas da angiog?nese associada ? inflama??o dos CRs e CDs.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-11T17:13:31Z No. of bitstreams: 1 PatriciaGuerraPeixeGoncalves_DISSERT.pdf: 943209 bytes, checksum: 858cf53a3d375685e3e69be1d38caba2 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-15T20:21:04Z (GMT) No. of bitstreams: 1 PatriciaGuerraPeixeGoncalves_DISSERT.pdf: 943209 bytes, checksum: 858cf53a3d375685e3e69be1d38caba2 (MD5) / Made available in DSpace on 2016-07-15T20:21:04Z (GMT). No. of bitstreams: 1 PatriciaGuerraPeixeGoncalves_DISSERT.pdf: 943209 bytes, checksum: 858cf53a3d375685e3e69be1d38caba2 (MD5) Previous issue date: 2016-02-22 / A angiog?nese e a linfangiog?nese s?o altera??es tamb?m decorrentes da inflama??o gengival provocada por microrganismos presentes no biofilme dental, bem como pela a migra??o de c?lulas de defesa e secre??o de mediadores inflamat?rios no local da agress?o. Este estudo teve por objetivo avaliar a angiog?nese e linfangiog?nese em 90 esp?cimes de bi?psias de tecido gengival clinicamente saud?vel, com gengivite e com periodontite cr?nicas. Os cortes histol?gicos foram avaliados pela colora??o de hematoxilina e eosina e pela t?cnica de imunoistoqu?mica atrav?s da imunomarca??o de CD34 e podoplanina, para avaliar, respectivamente, o ?ndice angiog?nico e linfangiog?nico, por meio da t?cnica de contagem microvascular. Os resultados mostraram que h? correla??o entre os ?ndices (p=0,030), por?m, mostrou que na periodontite h? menos n?meros de vasos linf?ticos do que no tecido gengival clinicamente saud?vel (p=0,016). A podoplanina mostrou marca??o no epit?lio e que h? rela??o da intensidade de marca??o com a intensidade do infiltrado inflamat?rio, sendo mais intensa a marca??o na presen?a de infiltrado inflamat?rio severo (p=0,033). Concluiu-se neste estudo que h? menor n?mero de vasos sangu?neos na periodontite em compara??o com a gengiva clinicamente saud?vel. As sinaliza??es presentes no processo inflamat?rio, bem como o real papel da vasculatura sangu?nea e linf?tica gengival ainda n?o est?o totalmente elucidadas / Angiogenesis and lymphangiogenesis are changes that occur due to gingival inflammation caused by microorganisms present in the biofilm, as well as the migration of immune cells and secretion of mediators in the aggressed site. This study aimed to research angiogenesis and lymphangiogenesis in 90 specimens of clinically healthy, with gingivitis and chronic periodontitis gingival tissue biopsies. The histological sections were evaluated by hematoxylin and eosin and the immunohistochemical technique through immunostaining for CD34 and podoplanin. To evaluate the angiogenic and lymphangiogenic indexes we performed a microvessel counting technique. The results showed that there is a correlation between the indexes (p = 0.030), however, we observed that periodontitis showed less lymphatic vessels than clinically healthy gingival tissue (p = 0.016). Podoplanin showed positive staining in the basal layers of the epithelium, and we observed a relationship between immunostaining intensity and the intensity of inflammatory infiltrate, with more intense staining in the presence of severe inflammatory infiltrate (p = 0.033). For this study, we concluded that there are fewer blood vessels in periodontitis compared with clinically healthy gingiva. The signaling present in the inflammatory process and the actual role of gingival blood and lymphatic vasculature are not fully understood, with further studies on angiogenesis and lymphangiogenesis being suggested.

Submitted by Setor de Tratamento da Informa??o - BC/PUCRS (tede2@pucrs.br) on 2016-06-28T19:56:24Z No. of bitstreams: 1 DIS_ANA_HELENA_BRETANHA_LOPES_TORT_COMPLETO.pdf: 1228563 bytes, checksum: 1ae15f2eb2fe5ed55580c78c418cb7be (MD5) / Made available in DSpace on 2016-06-28T19:56:24Z (GMT). No. of bitstreams: 1 DIS_ANA_HELENA_BRETANHA_LOPES_TORT_COMPLETO.pdf: 1228563 bytes, checksum: 1ae15f2eb2fe5ed55580c78c418cb7be (MD5) Previous issue date: 2016-02-15 / Gliomas are primary tumors of the central nervous system that are associated with a high mortality rate; they course with an average survival rate of 2 years after the diagnosis. Less than 5 % of glioma patients survive more than five years after diagnosis, even those treated with state of the art protocols, which include surgery, radiotherapy and chemotherapy. Tumors result from impairments of intracellular signaling pathways, including the p38/MAPK pathway, which, are responsible to control of cell proliferation and tumorigenesis, among other cellular responses. The goal of the present work was to investigate the effects of ML3403, an inhibitor of p38/MAPK, on the viability and proliferation of glioma cells, and to assess its effect when combined with bevacizumab (BVZ). BVZ already used in the clinical setting as anadjuvant for treating gliomas. It is a monoclonal antibody against VEGF-A receptor and thus reduces the signaling involved in tumor angiogenesis. U138 and U251 glioma cells were treated with ML3403 (0.1 to 200 ?M) and BVZ (1 to 200 ?g/mL) and later assessedfor cell viability, by MTT method and proliferation by cell counting. The results demonstrate that treatment with ML3403 reduces glioma cell viability and proliferation. Co-treatment with BVZ does not present any significant effect. The use of p38/MAPK inhibitors may constitute an interesting treatment against glioma progression. / Por serem tumores prim?rios localizados no sistema nervoso central, os gliomas apresentam altas taxas de mortalidade com sobrevida m?dia de dois anos. Menos de 5% dos pacientes com gliomas sobrevivem mais de cinco anos ap?s o diagn?stico, mesmo com os tratamentos mais avan?ados, os quais envolvem cirurgia, radia??o e quimioterapia. Os tumores resultam de diferentes defeitos em vias de sinaliza??o intracelulares, incluindo a via p38/MAPK. Entre as respostas celulares mediadas pela fam?lia de p38/MAPK, destaca-se a regula??o da produ??o do fator de crescimento endotelial vascular (VEGF). O objetivo deste trabalho foi investigar os efeitos de ML3403, um inibidor da p38/MAPK, sobre a viabilidade das c?lulas de glioma, e avaliar o seu efeito combinado com bevacizumab (BVZ). O BVZ, j? utilizado na cl?nica como adjuvante no tratamento de gliomas, ? um anticorpo monoclonal contra o receptor de VEGF-Ae reduz a sinaliza??o envolvida no processo de angiog?nese tumoral. As c?lulas de gliomas U138MG e U251MG foram tratadas com ML3403 (0,1 a 200?M) e BVZ (1 a 200 ?g/mL)e avaliadas para viabilidade celular, atrav?s do m?todo do MTT e prolifera??o celular, atrav?s da contagem do n?mero de c?lulas. Os resultados obtidos demonstraram redu??o da viabilidade e prolifera??o celular ap?s o tratamento com ML3403. O co-tratamento com BVZ n?o apresentou efeito aditivo. A utiliza??o de inibidores da via de sinaliza??o p38/MAPK pode ser considerada como um tratamento promissor na diminui??o do crescimento de gliomas.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2017-02-17T19:43:31Z No. of bitstreams: 1 LucianaMariaAraujoRabelo_TESE.pdf: 3802625 bytes, checksum: 997bf48b7638b7c1490b5a664ca3194e (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2017-02-20T18:59:27Z (GMT) No. of bitstreams: 1 LucianaMariaAraujoRabelo_TESE.pdf: 3802625 bytes, checksum: 997bf48b7638b7c1490b5a664ca3194e (MD5) / Made available in DSpace on 2017-02-20T18:59:27Z (GMT). No. of bitstreams: 1 LucianaMariaAraujoRabelo_TESE.pdf: 3802625 bytes, checksum: 997bf48b7638b7c1490b5a664ca3194e (MD5) Previous issue date: 2016-10-25 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq) / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / O c?ncer ? um termo utilizado para representar um conjunto de mais de 200 patologias, incluindo tumores malignos de diferentes localiza??es. V?rios s?o os mecanismos que contribuem para a carcinog?nese: sinal proliferativo sustentado, desregula??o da energia celular, evas?o a apoptose, indu??o a angiog?nese, replica??o ilimitada, entre outros. Dentre os principais tipos de c?ncer existentes, o c?ncer de pele se destaca: surge nos melan?citos e ? o mais frequente no Brasil, correspondendo a 30% de todos os tumores malignos registrados no Pa?s. Melanomas em est?gio inicial podem, na maioria das vezes, ser tratados apenas com cirurgia, por?m os c?nceres mais avan?ados requerem outros tratamentos. Neste trabalho, um inibidor de tripsina do tipo Kunitz foi purificado de sementes da leguminosa Mimosa regnellii Benth (ITJ), parcialmente caracterizado e avaliado quanto sua toxicidade frente a linhagens de c?lulas tumorais, atuando especificamente com um IC50 de 0,65 ?M em linhagem celular B16-F10, n?o apresentando toxicidade frente a linhagens de c?lulas n?o transformadas. Sua capacidade de induzir morte celular pela via de apoptose em c?lulas de melanoma de camundongo B16-F10 tamb?m foi avaliada, atrav?s de citometria de fluxo com os marcadores Anexina V-FITC/PI, induzindo cerca de 45% das c?lulas a apoptose. Al?m disso, o inibidor tamb?m foi avaliado quanto a sua capacidade de: alterar o potencial de membrana mitocondrial, visualizado por experimentos em citometria de fluxo utilizando a sonda Rodamina123 e microscopia confocal com o marcador Mitotracker Red, onde foi capaz de alterar de forma significativa o ??m; Liberar esp?cies reativas de oxig?nio e nitrog?nio, atrav?s de sondas espec?ficas visualizadas por t?cnicas de microscopia, causando libera??o de ROS na concentra??o de IC50, por?m n?o influenciando libera??o de ERNs; Liberar c?lcio citos?lico, evento que influencia na ativa??o de apoptose, com efeito significativo em c?lulas B16-f10; Inibir atividade angiog?nica de c?lulas endoteliais de coelho, atrav?s de experimentos de inibi??o de forma??o de novos vasos em matrigel, an?lise da express?o de VEGF por t?cnicas de western Blotting e redu??o da express?o de IL-6 analisado por microscopia confocal; Inibir o processo de migra??o celular em ensaio de indu??o de ferimento e an?lise em microscopia e, por fim, a alterar a morfologia celular de B16-F10, analisada por incuba??o com anticorpos espec?ficos para componentes da matriz extracelular e filamentos intermedi?rios das c?lulas de melanoma, realizados em microscopia de fluoresc?ncia. Todos esses resultados reunidos favorecem a proposi??o de um poss?vel mecanismo de a??o de ITJ na indu??o de morte celular por apoptose em c?lulas B16-F10, onde o inibidor atuaria inicialmente aumentando os n?veis de c?lcio citos?lico e ROS, alterando posteriormente a express?o de p53 em 36h de incuba??o, que agiriam alterando o metabolismo mitocondrial, ativando vias de apoptose dependentes da participa??o de caspases; ITJ tamb?m atuaria inibindo processos migrat?rios at? 18 horas de exposi??o, al?m de influenciar de forma tardia na inibi??o do processo angiog?nico in vitro. Estes resultados sugerem que ITJ apresenta potencial para ser utilizado como f?rmaco em tratamento adjuvante contra melanomas, devido a sua especificidade e baixa dosagem quando comparado a outras mol?culas bioativas. / Cancer is a term used to represent a set of more than 200 diseases, including malignant tumors of different localizations. There are several mechanisms that contribute to carcinogenesis: sustained proliferative signals, deregulation of cellular energy, evasion of apoptosis, angiogenesis induction and unlimited replication, among others. Among the main types of cancer, skin cancer stands out: arises in melanocytes and is the most common in Brazil, accounting for 30% of all malignant tumors registered in the country melanomas at an early stage can, in most cases,. It is treated with surgery, but the most advanced cancers require other treatments. In this work a Kunitz-type trypsin inhibitor was purified from Mimosa regnellii Benth (ITJ) legume seeds, partially characterized and evaluated for their toxicity front tumor cell lines, specifically acting with an IC50 of 0.65 ?M in B16-F10 cell line, showing no toxicity compared to non-transformed cell lines. Its ability to induce cell death by apoptosis pathway in mouse B16-F10 melanoma cells was evaluated by flow cytometry with Annexin V-FITC / PI markers, inducing about 45% apoptosis of cells. In addition, the inhibitor was also evaluated for their ability to: change the mitochondrial membrane potential, visualized by flow cytometry experiments using Rhodamine123 probe and confocal microscopy with Mitotracker Red marker, which was able to significantly change the ??m; Release of ROS and RNs through specific probes visualized by microscopy techniques, causing release of ROS in the concentration of IC50, but not influencing release RNS; Liberation of cytosolic calcium, an event that influences the apoptosis activation, with significant effect on B16-F10 cells; Inhibition of angiogenic activity on rabbit endothelial cells through experiments of inhibition of new vessel formation in Matrigel, analysis of VEGF expression by western blotting techniques and reduction of IL-6 expression analyzed by confocal microscopy; Inhibition of cell migration process in wound induction assay and microscopy analysis and, finally, to alter the cellular morphology of B16-F10 analyzed by incubation with specific antibodies to extracellular matrix components and intermediate filaments of melanoma cells, conducted in fluorescence microscopy. All these combined results favor the proposal of a possible ITJ action mechanism in the induction of cell death by apoptosis in B16-F10 cells, where the inhibitor initially act by altering the p53 expression in 36h of incubation, increasing calcium cytosolic levels and ROS, which would act changing the mitochondrial metabolism, activating dependent apoptosis pathways of caspase participation; ITJ also act by inhibiting migration processes up to 18 hours of exposure, as well as influence belatedly in inhibiting the angiogenic process in vitro. These results suggest that ITJ has the potential to be used as a drug adjuvant treatment for melanomas, due to their specificity and low-dose when compared to other bioactive molecules.

Submitted by PPG Medicina e Ci?ncias da Sa?de (medicina-pg@pucrs.br) on 2018-05-04T19:26:50Z No. of bitstreams: 1 DANIELE_CRISTOV?O_ESCOUTO.pdf: 3899595 bytes, checksum: 60af701fccf65168e901b103c704e2fe (MD5) / Rejected by Sheila Dias (sheila.dias@pucrs.br), reason: Devolvido devido ao t?tulo da capa (em ingl?s) estar diferente do t?tulo da folha de rosto e ficha catalogr?fica (em portugu?s). on 2018-05-16T19:01:31Z (GMT) / Submitted by PPG Medicina e Ci?ncias da Sa?de (medicina-pg@pucrs.br) on 2018-05-17T11:39:29Z No. of bitstreams: 1 DANIELE_CRISTOV?O_ESCOUTO.pdf: 3899595 bytes, checksum: 60af701fccf65168e901b103c704e2fe (MD5) / Rejected by Caroline Xavier (caroline.xavier@pucrs.br), reason: Devolvido devido ao t?tulo da capa (em ingl?s) estar diferente do t?tulo da folha de rosto e ficha catalogr?fica (em portugu?s). on 2018-05-28T18:04:10Z (GMT) / Submitted by PPG Medicina e Ci?ncias da Sa?de (medicina-pg@pucrs.br) on 2018-09-03T19:01:37Z No. of bitstreams: 1 DANIELE_CRIST?V?O_ESCOUTO.pdf: 2805745 bytes, checksum: c76c0d3c115aae92a7015f9312fd9604 (MD5) / Approved for entry into archive by Sheila Dias (sheila.dias@pucrs.br) on 2018-09-05T13:05:03Z (GMT) No. of bitstreams: 1 DANIELE_CRIST?V?O_ESCOUTO.pdf: 2805745 bytes, checksum: c76c0d3c115aae92a7015f9312fd9604 (MD5) / Made available in DSpace on 2018-09-05T13:40:27Z (GMT). No. of bitstreams: 1 DANIELE_CRIST?V?O_ESCOUTO.pdf: 2805745 bytes, checksum: c76c0d3c115aae92a7015f9312fd9604 (MD5) Previous issue date: 2018-03-19 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES / Introdu??o ? A distin??o adequada dos casos de alto risco para eventos graves nas doen?as hipertensivas gestacionais, n?o apenas pr?-ecl?mpsia, ? um desafio cl?nico. O modelo fullPIERS ? uma ferramenta simples e de baixo custo que utiliza vari?veis cl?nicas para estratificar a probabilidade de eventos adversos em gestantes com pr?-ecl?mpsia. O fator de crescimento placent?rio (PlGF) ? um biomarcador com concentra??es reduzidas no plasma de mulheres com pr?-ecl?mpsia e com crescente emprego na avalia??o de gestantes com suspeita de pr?-ecl?mpsia. Objetivos ? O objetivo deste estudo ? estimar a acur?cia do modelo fullPIERS e do biomarcador PlGF como preditores de desfechos adversos maternos em gestantes com doen?a hipertensiva gestacional. M?todos ? Estudo de coorte prospectiva em um hospital terci?rio em Porto Alegre, Brasil, que incluiu gestantes admitidas com press?o arterial sist?lica ? 140 e/ou press?o arterial diast?lica ? 90 mmHg a partir da 20? semana de gesta??o. Os piores valores de vari?veis cl?nicas e laboratoriais dentro das primeiras 48 horas de admiss?o foram coletados. Desenvolvimento de eventos adversos foi acompanhado por um per?odo de 14 dias. Concentra??es plasm?ticas maternas de PlGF do momento da admiss?o foram mensuradas. Resultados ? 405 gestantes foram inclu?das no estudo. Entre as 351 mulheres inclu?das na an?lise do modelo fullPIERS, 20 (5%) desenvolveram pelo menos um evento adverso materno dentro de 14 dias de interna??o. O modelo fullPIERS teve pouca capacidade discriminativa para prever desfechos em 48 horas [AUC 0,639 (95% CI 0,458-0,819)]. A acur?cia do modelo foi ainda mais baixa dentro de sete semanas da admiss?o [AUC 0,612 (95% CI 0,440-0,783)]; a capacidade discriminativa manteve-se similar dentro de 14 dias da admiss?o [AUC 0,637 (95% CI 0,491-0,783)]. A calibra??o do modelo fullPIERS tamb?m foi ruim: inclina??o 0,35 (95% CI 0,08-0,62) e intercepto 1,13 (95%CI -2,4-0,14). A an?lise do PlGF incluiu 392 gestantes. PlGF <5? percentil esteve associados a eventos adversos maternos dentro de 48 horas em gestantes inclu?das antes de 35 semanas com sensibilidade de 0,80 (0,4-0,96), valor preditivo negativo (VPN) de 0,98 (0,9-0,99) e AUC ROC de 0,672 (IC 95% 0,5-0,9). PlGF <100 pg/mL apresentaram sensibilidade de 0,8 (0,4-0,96), especificidade de 0,6 (0,5-0,7) e VPN de 0,99 (0,94-0,99) em mulheres ap?s 37 semanas de gravidez. PlGF apresentou bom desempenho para prever parto at? 14 dias em gestantes inclu?das antes de 35 semanas. PlGF <5? percentil esteve associado a rec?m-nascido pequeno para idade gestacional (PIG) com sensibilidade de 0,75 (0,6-0,9), especificidade 0,65 (0,5-0,7), NPV de 0,87 (0,79-0,94) e AUC ROC 0,698 (0,6-0,79), em gestantes com <35 semanas, a acur?cia diminuiu com o aumento das idades gestacionais. Conclus?es ? O modelo fullPIERS e a concentra??o de PLGF mostraram baixa acur?cia na predi??o de desfechos adversos maternos em mulheres com doen?a hipertensiva gestacional, incluindo pr?-ecl?mpsia. O modelo fullPIERS teve desempenho inferior na nossa amostra quando comparado com o estudo que validou este teste. O PLGF parece ser um biomarcador para uso como ferramenta adicional na predi??o de parto dentro de 14 dias e rec?m-nascidos PIG, especialmente em gestantes antes da 35? semana gestacional. / Introduction - Singling out high-risk patients from the diverse hypertensive disorders of pregnancy, and not only preeclampsia, is a challenge for clinicians. The fullPIERS model is a simple and low-cost evaluation instrument using clinical variables to stratify the adverse outcomes probability of pregnant women with high-risk preeclampsia. Placental growth factor (PlGF) levels are reduced in preeclampsia and are increasingly being used as a biomarker in the assessment of this disease. Objectives - The aim of the study is to evaluate the performance of the fullPIERS model and PlGF to predict adverse outcomes in women with hypertensive disorders of pregnancy. Methods - A prospective cohort study carried out at a teaching hospital in Porto Alegre, Brazil enrolling pregnant women admitted with a systolic blood pressure ? 140 mmHg and/or a diastolic blood pressure ? 90 mmHg from the 20th week of gestation. First 48 hours of admission worst clinical and laboratory data were recorded and the development of adverse maternal and perinatal outcomes scrutinised up to 14 days. Admission maternal plasma PlGF concentrations were measured. Results ? A total of 405 women were enrolled. From the 351 women included in the fullPIERS model analysis, 20 (5%) developed at least one of the combined maternal adverse outcomes. The fullPIERS model had poor outcomes discrimination at 48h [AUC 0.639 (95% CI 0.458-0.819)]. At the seventh admission day, the model?s accuracy was even lower [AUC 0.612 (95% CI 0.440-0.783)]; the model?s discriminative ability remained similar [AUC 0.637 (95% CI 0.491-0.783)] at 14 days. Calibration of the fullPIERS model was poor: slope - 0.35 (95% CI 0.08-0.62), intercept -1.13 (95%CI -2.4-0.14). PlGF analysis included 392 women. PlGF < 5th percentile predicted maternal adverse outcomes within 48h in women with gestation < 35 weeks with sensitivity of 0.80, NPV of 0.98 and AUC ROC of 0.672 (CI 95%0.5-0.9). The threshold of <100 pg/mL, had best accuracy in women after 37 weeks of pregnancy, sensitivity of 0.8, specificity of 0.6, negative predictive value of 0.99 and PPV of 0.04. PlGF had good performance to predict delivery within 14 days in women presenting before 35 weeks. PlGF <5th percentile predicted delivery of a SGA infant with sensitivity of 0.75, specificity 0.65, PPV of 0.45, NPV of 0.87, and AUC ROC 0.698, in women with gestation < 35 weeks, accuracy decreased at later gestational ages. Conclusion - In conclusion, in our sample the fullPIERS model and PlGF were limited predictors of maternal adverse outcomes in pregnant women with hypertensive disorders of pregnancy, including preeclampsia. The performance of the fullPIERS model in our sample was inferior to that of the original cohort. PlGF as a biomarker appears to be an additional tool to predict delivery within 14 days and SGA newborn in women before 35 weeks gestation.

Submitted by Rodrigo Martins Cruz (rodrigo.cruz@ufvjm.edu.br) on 2015-01-23T16:14:44Z No. of bitstreams: 5 saulo.pdf: 2174121 bytes, checksum: 837d6359c95ce3c616f0b0f600ff2489 (MD5) license_url: 52 bytes, checksum: 3d480ae6c91e310daba2020f8787d6f9 (MD5) license_text: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) license.txt: 2109 bytes, checksum: aa477231e840f304454a16eb85a9235f (MD5) / Approved for entry into archive by Rodrigo Martins Cruz (rodrigo.cruz@ufvjm.edu.br) on 2015-02-10T10:50:10Z (GMT) No. of bitstreams: 5 saulo.pdf: 2174121 bytes, checksum: 837d6359c95ce3c616f0b0f600ff2489 (MD5) license_url: 52 bytes, checksum: 3d480ae6c91e310daba2020f8787d6f9 (MD5) license_text: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) license.txt: 2109 bytes, checksum: aa477231e840f304454a16eb85a9235f (MD5) / Made available in DSpace on 2015-02-10T10:50:10Z (GMT). No. of bitstreams: 5 saulo.pdf: 2174121 bytes, checksum: 837d6359c95ce3c616f0b0f600ff2489 (MD5) license_url: 52 bytes, checksum: 3d480ae6c91e310daba2020f8787d6f9 (MD5) license_text: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) license.txt: 2109 bytes, checksum: aa477231e840f304454a16eb85a9235f (MD5) Previous issue date: 2013 / Muito ainda se discute com rela??o ? fisiopatologia das les?es perif?ricas de c?lulas gigantes (LPCG) e les?es centrais de c?lulas gigantes (LCCG). Ambas as les?es apresentam caracter?sticas cl?nicas distintas, apesar de possu?rem caracter?sticas histol?gicas semelhantes. Assim, estudos imunoistoqu?micos em LPCG e LCCG est?o sendo realizados, para permitir um melhor entendimento dessas les?es. Tem sido relatado que a express?o aumentada de FASN e a angiog?nese est?o diretamente ligadas com desenvolvimento dos tumores. No entanto, ainda n?o se sabe se estes eventos est?o envolvidos na patog?nese das LPCG e LCCG. O objetivo deste trabalho foi avaliar a express?o de FASN e o grau de angiog?nese entre LPCG e LCCG, al?m de verificar a correla??o entre essas vari?veis. Assim, 13 casos de LCCG e 14 casos de LPCG foram selecionados para an?lise da express?o imunoistoqu?mica de FASN, CD34, CD105 e D2-40. A express?o de FASN foi avaliada nos componentes celulares da les?o, seguida da mensura??o da densidade microvascular (DMV) e ?rea microvascular (AMV) para cada uma das amostras selecionadas. Os dados coletados foram submetidos ? an?lise descritiva e sequencialmente aos testes de Mann Whitney, teste t para amostras independentes e testes de correla??o de Pearson e Spearman. Os resultados do nosso estudo indicam que: (1) n?o h? diferen?as na imunoexpress?o de FASN entre os grupos de les?es (CM ? 8% FASN+ / CGM ? 38% FASN+); (2) LPCG possuem maior DMV em CD34; n?o houve diferen?as na DMV em CD105 e D2-40 entre as les?es. A AMV em LPCG foi maior que em LCCG para CD34, CD105 e D2-40; (3) em LPCG houve correla??o positiva entre (CM ? FASN+ com DMV/CD105); (4) nas LCCG houve correla??o positiva entre (CM ? FASN+ com DMV/CD105), (CM ? FASN+ com AMV/CD105 e CD34), (CGM ? FASN+ com AMV/CD105). A partir dos resultados obtidos concluiu-se que os n?veis similares da express?o imunoistoqu?mica de FASN indicam processos constitutivos da manuten??o tissular de ambas as les?es. No entanto, as diferen?as na vasculariza??o, entre os grupos de les?es, parecem ser influenciadas por CM positivas para FASN. / Disserta??o (Mestrado) ? Programa de P?s-Gradua??o em Odontologia, Universidade Federal dos Vales do Jequitinhonha e Mucuri, 2012. / ABSTRACT There is still a lot of discussion about the pathophysiology of Peripheral Giant Cell Lesion (PGCL) and Central Giant Cell Lesion (CGCL). These lesions show distinct clinical features, although they have similar histological characteristics. Thus, immunohistochemical studies in PGCL and CGCL are being done to improve understanding these diseases. It has been reported that high level of FASN and angiogenesis are linked with tumors development. However, remains unknown whether these events are involved in the pathogenesis of LPCG and LCCG. The aim of this research was to study FASN expression and angiogenesis degree between PGCL and CGCL, in addition, verify the correlation between this variables. Thus, 13 cases of CGCL and 14 cases of PGCL were selected and examined by immunoexpression of FASN, CD34, CD105 and D2-40. The immunoexpression of FASN was assessed in components cells of lesions, followed by measurement of Microvassel Density (MVD) and Microvassel Area (MVA) for each selected sample. Data collected was submitted to descriptive analysis and followed by Mann Whitney test, ?t? test to independent samples and Person?s and Spearman?s correlation. The results of this study indicate that: (1) there are no differences in FASN immunoexpression between group lesions (MC ? 8% FASN+ / MGC ? 38% FASN+); (2) PGCL have greater MVD in CD34 than CGCL; there are no MDV differences in CD105 and D2-40 between lesions. PGCL have greater MVA in CD34, CD105 and D2-40 than CGCL; (3) in PCGL there was a positive correlation between (MC ? FASN+ and MVD/CD105); (4) in CGCL there was a positive correlation between (MC ? FASN+ and MVD/CD105), (MC ? FASN+ and MVA/CD105 and CD34), (MGC ? FASN+ and MVA/CD105). With base on these results it is concluded that similar expression of FANS levels indicate constituent process of tissue maintenance in both lesions. On the other hand, differences on angiogenesis between lesions seem be influenced by FASN+ mononuclear cells.